// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























3340 Abstracts

Outcomes of MitraClip Repair in Primary Mitral Regurgitation Patients With STS Repair Score of Less Than 6% and STS Replacement Score of Less Than 8%: Results From the Global EXPAND Study

Gilbert Tang - Transcatheter Cardiovascular Therapeutics (TCT) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Prognostic Importance of Functional Status Versus Health Status in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Suzanne Arnold - Transcatheter Cardiovascular Therapeutics (TCT) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Hybrid Transcatheter and Minimally Invasive Left Ventricular Reconstruction for the Treatment of Ischemic Cardiomyopathy: Midterm Results

Patrick Klein - Transcatheter Cardiovascular Therapeutics (TCT) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Health Status Improvements Following Transcatheter Tricuspid Repair With the PASCAL Device in the CLASP TR Early Feasibility Study

Matthew Reynolds - Transcatheter Cardiovascular Therapeutics (TCT) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Outcomes with General Anesthesia Compared to Conscious Sedation in Patients Undergoing Transcatheter Aortic Valve Replacement

Rosemary Hansen - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Quality of Life Outcomes in Transcatheter Aortic Valve Replacement Patients Requiring Pacemaker Implantation

Aishwarya Bhardwaj - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Functional Status after Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis from the SURTAVI Trial

Jeffrey J. Popma - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

There’s More to the ECG: Predictors of Complete Heart Block after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Justin Heizer - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Comparison of the long-term results of ASA and surgical myoectomy in patients with obstructive form of hypertrophic cardiomyopathy

Roman Naydenov - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Effect of a Mechanical-Expanding vs. Self-Expanding Transcatheter Valve Prosthesis on Health Status in Patients with Severe Aortic Stenosis at High Surgical Risk: Results from the REPRISE III Trial

Suzanne Baron - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Race-based Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Study

Saraschandra Vallabhajosyula - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Early Changes in Quality of Life after Transcatheter Aortic Valve Replacement: Results from the 3M-TAVR Trial

Sandra Lauck - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Evaluation of microvascular dysfunction in patients with Takotsubo syndrome

Domenico Nobile - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Ischemic Stroke in Patients with Takotsubo Cardiomyopathy: Analysis of the National Inpatient Sample Database

Shunsuke Aoi - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Coronary and myocardial haemodynamic effects of Impella LV unloading in patients undergoing high-risk percutaneous coronary intervention

Natalia Briceno - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Evaluation of the impact of a chronic total coronary occlusion on ventricular arrhythmias and long-term mortality in patients with ischemic cardiomyopathy and an implantable cardioverter-device (the eCTOpy-in-ICD study)

Ivo M. van Dongen - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Influence of Hospital Characteristics on the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Study

Saraschandra Vallabhajosyula - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Can Cardiac MRI Viability Assessment Guide Revascularization Decisions in Patients with Ischemic Cardiomyopathy?

Demetrios Doukas - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Septal Alcohol Ablation Versus Myectomy for Symptomatic Hypertrophic Obstructive Cardiomyopathy: An Updated Meta-analysis for Long Term Outcomes

Mohammed Osman - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Outcomes of Acute Myocardial Infarction in Hypertrophic Obstructive Cardiomyopathy

Obai Abdullah - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Heart muscle disease

N/A

Copyright © 2026. QuantiNova All rights reserved